Brief: QuidelOrtho Receives De Novo FDA Authorization For Sofia 2 SARS Antigen+ FIA

Quidelortho

08/03/2023 21:06

March 8 (Reuters) - Quidelortho Corp  QDEL.O :
    * QUIDELORTHO RECEIVES DE NOVO FDA AUTHORIZATION FOR SOFIA®
2 SARS
ANTIGEN+ FIA
    * QUIDELORTHO : GRANTED DE NOVO REQUEST FROM U.S. FOOD AND
DRUG
ADMINISTRATION (FDA), ALLOWING COMPANY TO MARKET ITS NEW SOFIA®
2 SARS ANTIGEN+ FIA

Source text for Eikon:  ID:nBw22fFSa 
Further company coverage:  QDEL.O 

 ((Reuters.Briefs@thomsonreuters.com;))